Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FNMVN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,225
Award facts
- Contract value 100% obligated
- $49,224.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $49,224.90 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. The contract is issued under a firm fixed-price arrangement with an ultimate completion date of August 26, 2025. This delivery order was executed without set-aside designation, allowing the vendor to compete directly in the open federal procurement market despite its small business status.
This award represents a task order executed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499.999 billion and extending through November 2026. The IDC establishes a comprehensive pharmaceutical supply vehicle enabling the DLA to issue delivery orders for branded and generic prescription drugs, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. Keytruda, an oncology therapeutic, aligns with the vendor's demonstrated expertise in distributing specialized pharmaceutical products to military health systems. DMS Pharmaceutical Group's consistent receipt of DLA delivery orders across diverse pharmaceutical categories establishes the company as a key participant in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FNMVN?
SPE2DB25FNMVN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FNMVN worth?
The government has obligated $49,225 on SPE2DB25FNMVN.
Is contract SPE2DB25FNMVN an order under another contract?
Yes. SPE2DB25FNMVN is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB25FNMVN competed?
The extent of competition for SPE2DB25FNMVN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award